DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Inoue H, Umeyama M, Yamada T, Hashimoto H, Komoto A, Yasaka M.
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: a sub-analysis of the STANDARD study.
J Cardiol 2020;
75 (02) 208-215
We do not assume any responsibility for the contents of the web pages of other providers.